Following multiple House hearings, the Senate Health, Education, Labor and Pensions committee held its first hearing on Tuesday to reauthorize the US Food and Drug Administration’s (FDA) user fee ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results